Inventor
COHEN CHARLES M
US50 patents
⚠️ This page may combine multiple inventors who share the name “COHEN CHARLES M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CREATIVE BIOMOLECULES INC
26 patentsUS5674844AOct 7, 1997
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
CREATIVE BIOMOLECULES INC118 citations99
US5013653AMay 7, 1991
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
CREATIVE BIOMOLECULES INC418 citations99
US5656593AAug 12, 1997
Morphogen induced periodontal tissue regeneration
CREATIVE BIOMOLECULES INC61 citations96
US5330902AJul 19, 1994
Leader sequences for the production of recombinant proteins
CREATIVE BIOMOLECULES INC40 citations96
US5215896AJun 1, 1993
Leader sequences for the production of recombinant proteins
CREATIVE BIOMOLECULES INC41 citations96
US5197973AMar 30, 1993
Synthetic bioadhesive
CREATIVE BIOMOLECULES INC92 citations96
US4743679AMay 10, 1988
Process for producing human epidermal growth factor and analogs thereof
CREATIVE BIOMOLECULES INC91 citations96
US6194376B1Feb 27, 2001
Method for modulating inflammatory response comprising administering morphogen
CREATIVE BIOMOLECULES INC22 citations93
US6090776AJul 18, 2000
Morphogen treatment of organ implants
CREATIVE BIOMOLECULES INC30 citations93
US6022853AFeb 8, 2000
Morphogen-enriched dietary composition
CREATIVE BIOMOLECULES INC53 citations93
US5854071ADec 29, 1998
OP-3- induced morphongenesis
CREATIVE BIOMOLECULES INC18 citations93
US5849686ADec 15, 1998
Morphogen-induced liver regeneration
CREATIVE BIOMOLECULES INC49 citations93
US5741641AApr 21, 1998
Morphogenic protein screening method
CREATIVE BIOMOLECULES INC30 citations93
US5739107AApr 14, 1998
Morphogen treatment of gastrointestinal ulcers
CREATIVE BIOMOLECULES INC36 citations93
US5733878AMar 31, 1998
Morphogen-induced periodontal tissue regeneration
CREATIVE BIOMOLECULES INC30 citations93
US5652337AJul 29, 1997
OP-3-induced morphogenesis
CREATIVE BIOMOLECULES INC27 citations93
US5650276AJul 22, 1997
Morphogenic protein screening method
CREATIVE BIOMOLECULES INC29 citations93
US5972884AOct 26, 1999
Morphogen treatment of gastrointestinal ulcers
CREATIVE BIOMOLECULES INC28 citations92
US5374431ADec 20, 1994
Synthetic bioadhesive
CREATIVE BIOMOLECULES INC35 citations92
US5302526AApr 12, 1994
Recombinant DNA enclosed amphiphilic leader sequences for the production and purification of fusion proteins
CREATIVE BIOMOLECULES INC29 citations92
US6077823AJun 20, 2000
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
CREATIVE BIOMOLECULES INC18 citations84
US5004686AApr 2, 1991
Process for producing human epidermal growth factor and analogs thereof
CREATIVE BIOMOLECULES INC19 citations82
US5994131ANov 30, 1999
Morphogenic protein screening method
CREATIVE BIOMOLECULES INC7 citations74
US5707810AJan 13, 1998
Method of diagnosing renal tissue damage or disease
CREATIVE BIOMOLECULES INC16 citations74
US5416007AMay 16, 1995
Enhanced proteolytic cleavage of recombinant fusion proteins
CREATIVE BIOMOLECULES INC16 citations74
US5700677ADec 23, 1997
Protein analogues of tissue plasminogen activator
CREATIVE BIOMOLECULES INC2 citations57
CURIS INC
16 patentsUS6861404B1Mar 1, 2005
Therapies for chronic renal failure
CURIS INC82 citations96
US6565843B1May 20, 2003
Protein-induced tissue morphogenesis
CURIS INC37 citations96
US6498142B1Dec 24, 2002
Morphogen treatment for chronic renal failure
CURIS INC56 citations96
US6333312B1Dec 25, 2001
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
CURIS INC51 citations96
US7147839B2Dec 12, 2006
Methods for evaluating tissue morphogenesis and activity
CURIS INC28 citations93
US6723698B2Apr 20, 2004
Methods and compositions for the treatment of motor neuron injury and neuropathy
CURIS INC29 citations93
US6531445B1Mar 11, 2003
Protein-induced morphogenesis in liver tissue
CURIS INC34 citations93
US6506729B1Jan 14, 2003
Methods and compositions for the treatment and prevention of Parkinson's disease
CURIS INC32 citations93
US6495513B1Dec 17, 2002
Morphogen-enhanced survival and repair of neural cells
CURIS INC31 citations93
US6399569B1Jun 4, 2002
Morphogen treatments for limiting proliferation of epithelial cells
CURIS INC17 citations93
US6800603B2Oct 5, 2004
Morphogen-induced neural cell adhesion
CURIS INC19 citations84
US7196056B2Mar 27, 2007
Protein-induced morphogenesis of kidney tissue
CURIS INC6 citations74
US6211146B1Apr 3, 2001
60A protein-induced morphogenesis
CURIS INC14 citations74
US7056882B2Jun 6, 2006
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
CURIS INC9 citations73
US6288031B1Sep 11, 2001
Method for reducing extravasation of effector cells
CURIS INC13 citations73
US7060680B2Jun 13, 2006
Morphogen treatments for limiting proliferation of epithelial cells
CURIS INC0 citations52
STRYKER CORP
5 patentsUS8017580B2Sep 13, 2011
Therapies for chronic renal failure
STRYKER CORP4 citations74
US6153583ANov 28, 2000
OP-3 induced morphogenesis
STRYKER CORP12 citations74
US7524817B2Apr 28, 2009
Therapies for chronic renal failure
STRYKER CORP7 citations72
US7557078B1Jul 7, 2009
Morphogen-induced nerve regeneration and repair
STRYKER CORP3 citations63
US8377878B2Feb 19, 2013
Therapies for chronic renal failure
STRYKER CORP0 citations52